Teva's collapse – Israel's biotech recovery - The Jerusalem Post
Most Active Foreign Bonds 21.05.2021 – Teva Pharma, Gazprom, New York Life, Deutsche Bahn, Russian Railways, UBS London Branch – Financial Markets Blog
UBS nedjusterer Teva Pharmaceuticals efter Kåre Schultz indgår forlig i USA
Quest upgraded while Teva downgraded at UBS, and VectiveBio scores two new buy initiations in today's analyst action - ADVFN
Brussels' Teva probe reveals dark side of patent protections | Financial Times
UBS reiterates Teva's Buy rating but cuts price target - Globes
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Watch What You Need to Know: China, UBS, TEVA - Bloomberg
UBS applauds Teva for Auspex acquisition - Globes
Opioid Epidemic Settlement? What Purdue's Rumored Deal Means For Teva, Allergan | Investor's Business Daily
UBS — EMMA KOLB
Rhode Island takes Teva to trial in multibillion-dollar opioid case | Nasdaq
Generic Drug Lawsuit Could Mean Big Fines for Teva, Mylan: UBS
Rebounding Teva is 'too cheap to ignore,' upbeat analysts say | Fierce Pharma
UBS Sees China Private Banking Revenue Pool Hitting $163 Billion - BNN Bloomberg
Why Teva Pharmaceutical Industries, Intrepid Potash, and Ensco Slumped Today | Nasdaq
UBS raises Teva price target - Globes
Teva: 35% of senior management are women - Globes
Exclusive: UBS in talks with China Life for China asset management JV - sources - Headquarters Finance
A Look At Teva's Paragard IUD Asset Sale To Cooper Companies, From Both Sides
Miles O'Meara - New York City Metropolitan Area | Professional Profile | LinkedIn
Teva stock downgraded to neutral by UBS on heels of $85 million opioid settlement - MarketWatch
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma
TEVA Institutional Ownership - Teva Pharmaceutical Industries Ltd. (NYSE) Stock
Stock Picks to Buy, 13 Contrarian Names and Rationale for Each: UBS
Teva's Legal Overhang Triggers UBS Downgrade, Near-Halving Of Price Target
